Obesity clinical trial success rates for novel drugs U.S. 2006-2015 by phase
This statistic depicts the percentage of obesity clinical trials for novel drugs that were successful in the period from 2006 to 2015, by phase and indication. According to the data, among obesity NME/biologics just 1.4 percent were successful from phase I to approval.